NeoGenomics, Inc. announced that Chief Strategy and Corporate Development Officer, Douglas Brown will be leaving the Company on May 27th to pursue other interests. Chief Financial Officer, William Bonello, and Chief Culture Officer, Jennifer Balliet, will continue to serve in their current roles.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.01 USD | -0.69% | -7.47% | -19.59% |
05-28 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
05-02 | North American Morning Briefing : Stock Futures -3- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.59% | 1.66B | |
-17.05% | 8.42B | |
+67.76% | 4.31B | |
+3.94% | 2.72B | |
-2.80% | 2.62B | |
-53.41% | 1.9B | |
-21.62% | 1.42B | |
+16.16% | 1.2B | |
-46.45% | 1.11B | |
+14.78% | 967M |
- Stock Market
- Equities
- NEO Stock
- News NeoGenomics, Inc.
- NeoGenomics, Inc. Announces Resignation of Douglas Brown as Chief Strategy and Corporate Development Officer